Ken Griffin Wave Life Sciences Ltd. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $60,444 - $89,424	-13,800 Reduced 49.29%	14,200 $70,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $45,312 - $87,552	12,800 Added 84.21%	28,000 $172,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $63,232 - $104,424	15,200 New	15,200 $76,000
Q2 2023 Aug 14, 2023	BUY	$3.51 - $4.69 $2,808 - $3,752	800 Added 10.13%	8,700 $31,000
Q1 2023 May 15, 2023	SELL	$3.58 - $6.3 $39,738 - $69,930	-11,100 Reduced 58.42%	7,900 $34,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $7.0 $13,356 - $29,400	-4,200 Reduced 18.1%	19,000 $133,000
Q3 2022 Nov 14, 2022	SELL	$2.37 - $4.28 $1,422 - $2,568	-600 Reduced 2.52%	23,200 $84,000

146

93.1M

33K

57.2K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $454M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.